Search results
Illumina (ILMN) Advances in NGS With DRAGEN v4.3 Launch
Zacks via Yahoo News· 3 weeks agoIllumina, Inc. ILMN has progressed in genomic research with the recent launch of DRAGEN v4.3. This...
The Zacks Analyst Blog Highlights Union Pacific, Freeport-McMoRan, Block, Xcel and Illumina
Zacks via Yahoo News· 2 months agoFor Immediate Release Chicago, IL – May 15, 2024 – Zacks.com announces the list of stocks featured...
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Zacks via Yahoo News· 2 months agoIllumina Inc. ILMN reported first-quarter 2024 adjusted earnings per share (EPS) of 9 cents, which...
Is Trending Stock Illumina, Inc. (ILMN) a Buy Now?
Zacks via Yahoo News· 2 years agoZacks.com users have recently been watching Illumina (ILMN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Illumina (ILMN), Nashville Biosciences Partner With Amgen
Zacks via Yahoo News· 1 year agoIllumina ILMN, together with Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt...
Illumina (ILMN) Stock Moves -1.61%: What You Should Know
Zacks via Yahoo News· 2 years agoIllumina (ILMN) closed the most recent trading day at $190.38, moving -1.61% from the previous...
Celularity, Inc. (CELU) Q2 Earnings Beat Estimates
Zacks via Yahoo News· 2 years agoCelularity, Inc. (CELU) delivered earnings and revenue surprises of 111.54% and 32.66%, respectively, for the quarter ended June 2022. Do the numbers...
Clene Inc. (CLNN) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo News· 2 years agoClene Inc. (CLNN) possesses the right combination of the two key ingredients for a likely earnings...
Illumina (ILMN) Q3 Earnings Beat Estimates, '22 View Slashed
Zacks via Yahoo News· 2 years agoDelays in instruments and consumables purchases, negative foreign exchange impact and consumables...
Illumina (ILMN) Q4 Earnings Miss Estimates, Gross Margin Down
Zacks via Yahoo News· 1 year agoDelays in recruitment for some large research projects in the Americas and Europe, the impact of...